Status:
COMPLETED
Sialendoscopy in Treatment of Submandibular Gland Sialolithiasis
Lead Sponsor:
Centre Hospitalier Régional Metz-Thionville
Conditions:
Lithiasis
Eligibility:
All Genders
18+ years
Brief Summary
Salivary disorders are common reason for ENT specialist consultation. Sialolithiasis are the most frequent salivary obstruction disease and are characterized by the development of calcified structures...
Eligibility Criteria
Inclusion
- Adult patient
- Patient treated in CHR Metz-Thionville between 2013 and 2020
- With a pathological impairment (suspected or confirmed) of a salivary gland
- With sialendoscopy indication for diagnosis and/or treatment
Exclusion
- Opposed to use data
- Without sialendoscopy indication
- Without lithiasis salivary gland disorder
- With parotid gland lithiasis
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 25 2021
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT04886440
Start Date
January 1 2021
End Date
March 25 2021
Last Update
August 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHR Metz Thionville
Metz, Moselle, France, 57085